Last reviewed · How we verify
Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation (RAFTING)
To compare the efficacy of switching to a different molecular target (from TNF to IL6) versus cycling to a second TNF inhibitor in patients with active RA, who have not adequately responded to a previous treatment with a first anti-TNF.
Details
| Lead sponsor | Mario Negri Institute for Pharmacological Research |
|---|---|
| Phase | PHASE4 |
| Status | TERMINATED |
| Enrolment | 208 |
| Start date | Thu Mar 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Dec 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Rheumatoid Arthritis
Interventions
- Tocilizumab
- Etanercept
- Infliximab
- Adalimumab
- Golimumab
- Certolizumab Pegol
Countries
Italy